In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Tularik, Amgen discover and develop cancer therapeutics

Executive Summary

Tularik and Amgen will work together on the discovery, development and marketing of oncology therapeutics over a five-year period. Amgen will initially choose development projects from Tularik's targets but expects to expand beyond these 30 amplified oncogenes.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing
    • Includes Contract
    • Intra-Biotech Deal
    • Includes Equity

Related Companies

Advertisement
UsernamePublicRestriction

Register